ClinicalTrials.Veeva

Menu

Novel Screening Modality for Early Gastric Cancer

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Completed

Conditions

Gastric Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT04114006
IRB00001470

Details and patient eligibility

About

Potential patients will be recruited at participating sites based on routine care with clinical indications for upper endoscopy. Following informed consent, patients will undergo their scheduled endoscopy with standard forceps biopsies along with the transepithelial brush samples. All samples, biopsy and brush samples, will be sent for pathology analysis, per standard clinical practice.

Full description

Potential patients will be recruited at participating sites based on routine care with clinical indications for upper endoscopy. Following informed consent, patients will undergo their scheduled endoscopy with standard forceps biopsies along with the transepithelial brush samples. All samples, biopsy and brush samples, will be sent for histologic analysis, with planned study of the diagnostic yields of each method.

Enrollment

120 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subject is informed of the investigational nature of this study and given verbal and written informed consent in accordance with local, U.S., and international guidelines.
  • Both males and females at least 18 years.
  • Patients with clinical indications for upper endoscopy

Exclusion criteria

  • Patients should not have an advanced medical or psychiatric conditions which that may limit their ability to participate in the study, as judged by the physician.

Trial contacts and locations

1

Loading...

Central trial contact

Tatiana Torres Herman, MD, MHS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems